Renal Cell Carcinoma

Molecular Targets and Clinical Applications, Second Edition

Nonfiction, Health & Well Being, Medical, Specialties, Radiology & Nuclear Medicine, Oncology
Cover of the book Renal Cell Carcinoma by , Humana Press
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9781597453325
Publisher: Humana Press Publication: February 8, 2009
Imprint: Humana Language: English
Author:
ISBN: 9781597453325
Publisher: Humana Press
Publication: February 8, 2009
Imprint: Humana
Language: English

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

In the second edition of their critically acclaimed book, Ronald Bukowski, Robert Motzer, and Robert Figlin have thoroughly updated and expanded their survey of clinical, biological and pathological management of localized and advanced renal cell carcinoma. A panel of internationally renowned contributors explores the latest developments in molecular genetics, focusing on the novel targets that have been discovered in epithelial renal tumors. The discussion includes the specific biology of selected target molecules or receptors and the various agents that inhibit these targets, including full chapters devoted to drugs that selectively inhibit receptor tyrosine kinases, such as sunitinib and axitinib. Further attention is paid to leading-edge strategies that target and inhibit tumor associated angiogenesis and block the vascular endothelial growth factor pathway. Comprehensive and authoritative, Renal Cell Carcinoma: Molecular Targets and Clinical Applications, Second Edition is the definitive text on the rapidly evolving landscape of experimental therapeutics, written and edited by the pioneers of the field.

More books from Humana Press

Cover of the book Privacy and Health Care by
Cover of the book Quiet Lives by
Cover of the book Neuroinflammation by
Cover of the book Clinical Evaluation and Management of Spasticity by
Cover of the book Autoimmune Endocrinopathies by
Cover of the book Targeted Therapies by
Cover of the book The Protein Protocols Handbook by
Cover of the book The Cannabinoid Receptors by
Cover of the book Challenging Cases in Allergy and Immunology by
Cover of the book Essentials of Apoptosis by
Cover of the book Oxidative Stress and Free Radical Damage in Neurology by
Cover of the book Bone Densitometry in Clinical Practice by
Cover of the book Colorectal Cancer Screening by
Cover of the book Handbook of Mental Health and Acculturation in Asian American Families by
Cover of the book Applications of Biotechnology in Cardiovascular Therapeutics by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy